Chronic Lymphocytic Leukemia

The Pharmacy Times® Chronic Lymphocytic Leukemia Resource Center is a comprehensive resource for clinical news and expert insights on treatments for chronic lymphocytic leukemia.


Latest News

Antibody immunoglobulin.
Routine Immunoglobulin G Testing Reduces Infections in Patients with Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia

July 1st 2024

Increased immunoglobulin replacement therapy led to reduced infections and managed secondary immune deficiencies such as hypogammaglobulinemia.

cll/sll/Image Credit: © Graphicroyalty - stock.adobe.com
Long-Term Follow-Up of Ibrutinib in CLL/SLL: Insights and Outcomes

July 1st 2024

Immunoglobulin G test -- Image credit: jarun011 | stock.adobe.com
IgRT in Patients With CLL, NHL Associated With Lower Odds of Infections and Associated Antimicrobial Use

June 28th 2024

Zanubrutinib Emerges as Potential First-Line Therapy in Patients with High-Risk CLL/SLL
Zanubrutinib Emerges as Potential First-Line Therapy in Patients with High-Risk CLL/SLL

June 14th 2024

CLL in blood -- Image credit: Dr_Microbe | stock.adobe.com
Covalent BTK Inhibitors: A Review of the Evidence in Chronic Lymphocytic Leukemia

June 14th 2024

Video Interviews
Latest CME Events & Activities

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Chronic Myeloid Leukemia: Navigating Drug Resistance and Optimizing Care

1.0 Credit / Hematologic Cancer, Hematology, Oncology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Recent Advances in BCMA-Directed Treatment in Multiple Myeloma: Insights and Application for Managed Care

1.0 Credits / Hematologic Cancer, Oncology

View More

Revolutionizing Multiple Myeloma Care: CAR T-Cell Therapy, Bispecific Antibodies, and Patient-Centered Strateg...

1.0 Credit / Oncology, Hematologic Cancer

View More

Optimizing JAK Inhibitor Therapy for Myelofibrosis: Insights for Oncology Pharmacists

1.0 Credit / Hematologic Cancer, Oncology

View More

New Frontiers in the Treatment of Lower-Risk Myelodysplastic Syndromes: Bridging Clinical Innovation and Pract...

1.0 Credit / Hematologic Cancer, Oncology

View More

Elevating Safety and Adherence in Chronic Myeloid Leukemia Through Oncology Pharmacist Expertise

1.0 Credit / Hematologic Cancer, Oncology

View More

Optimizing Bispecific Antibody Utilization in Non-Hodgkin Lymphoma: Addressing Challenges in Community-Based C...

1.0 Credit / Hematologic Cancer, Oncology

View More

Navigating Chronic Lymphocytic Leukemia Therapy and Cardiovascular Comorbidities: Clinical Recommendations and...

1.0 Credit / Hematologic Cancer

View More

Enhancing Bruton Tyrosine Kinase Inhibitor Outcomes in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: ...

1.0 Credit / Hematologic Cancer

View More

Balancing Innovation and Implementation: A Comprehensive Approach to CAR T, Bispecific Antibodies, and Operati...

1.0 Credit / Hematologic Cancer, Oncology

View More

Finding Balance Between Advancement and Application: A Guide for Community Oncology Pharmacists on CAR T-Cell ...

0.75 Credit / Oncology, Hematologic Cancer

View More

Keeping Pace With New Developments in Multiple Myeloma: Updates and Strategies to Optimize Bispecific Antibodi...

1.5 Credits / Oncology, Hematology, Hematologic Cancer

View More

Addressing the Gaps and Clinical Challenges in Chronic Lymphocytic Leukemia: Updates and Strategies for Manage...

1.5 Credits / Hematology, Hematologic Cancer, Oncology

View More

Navigating Long-Term Toxicities of CAR T-Cell Therapy: Educational Insights for Oncology Pharmacists

1.25 Credits / Oncology, Hematologic Cancer

View More

More News

© 2024 MJH Life Sciences

All rights reserved.